Literature DB >> 20729402

Upregulation of eNOS and unchanged energy metabolism in increased susceptibility of the aging type 2 diabetic GK rat heart to ischemic injury.

Martine Desrois1, Kieran Clarke, Carole Lan, Christiane Dalmasso, Mark Cole, Bernard Portha, Patrick J Cozzone, Monique Bernard.   

Abstract

We investigated the tolerance of the insulin-resistant diabetic heart to ischemic injury in the male Goto-Kakizaki (GK) rat, a model of type 2 diabetes. Changes in energy metabolism, nitric oxide (NO) pathway, and cardiac function were assessed in the presence of physiological substrates. Age-matched control Wistar (n = 19) and GK (n = 18) isolated rat hearts were perfused with 0.4 mM palmitate, 3% albumin, 11 mM glucose, 3 U/l insulin, 0.2 mM pyruvate, and 0.8 mM lactate for 24 min before switching to 1.2 mM palmitate (11 rats/group) during 32 min low-flow (0.5 ml·min(-1)·g wet wt(-1)) ischemia. Next, flow was restored with 0.4 mM palmitate buffer for 32 min. A subset of hearts from each group (n = 8 for control and n = 7 for GK groups) were freeze-clamped for determining baseline values after the initial perfusion of 24 min. ATP, phosphocreatine (PCr), and intracellular pH (pH(i)) were followed using (31)P magnetic resonance spectroscopy with simultaneous measurement of contractile function. The NO pathway was determined by nitric oxide synthase (NOS) isoform expression and total nitrate concentration (NOx) in hearts. We found that coronary flow was 26% lower (P < 0.05) during baseline conditions and 61% lower (P < 0.05) during reperfusion in GK vs. control rat hearts. Rate pressure product was lower during reperfusion in GK vs. control rat hearts (P < 0.05). ATP, PCr, and pH(i) during ischemia-reperfusion were similar in both groups. Endothelial NOS expression was increased in GK rat hearts during baseline conditions (P < 0.05). NOx was increased during baseline conditions (P < 0.05) and after reperfusion (P < 0.05) in GK rat hearts. We report increased susceptibility of type 2 diabetic GK rat heart to ischemic injury that is not associated with impaired energy metabolism. Reduced coronary flow, upregulation of eNOS expression, and increased total NOx levels confirm NO pathway modifications in this model, presumably related to increased oxidative stress. Modifications in the NO pathway may play a major role in ischemia-reperfusion injury of the type 2 diabetic GK rat heart.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20729402      PMCID: PMC2993220          DOI: 10.1152/ajpheart.00998.2009

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  71 in total

1.  Putting the genes for type II diabetes on the map.

Authors:  K Almind; A Doria; C R Kahn
Journal:  Nat Med       Date:  2001-03       Impact factor: 53.440

Review 2.  Nitric oxide and cardiac function: ten years after, and continuing.

Authors:  P B Massion; O Feron; C Dessy; J-L Balligand
Journal:  Circ Res       Date:  2003-09-05       Impact factor: 17.367

3.  Cardiac remodeling rather than disturbed myocardial energy metabolism is associated with cardiac dysfunction in diabetic rats.

Authors:  Entela Bollano; Elmir Omerovic; Helen Svensson; Finn Waagstein; Michael Fu
Journal:  Int J Cardiol       Date:  2007-01-08       Impact factor: 4.164

4.  Endothelial dysfunction and salt-sensitive hypertension in spontaneously diabetic Goto-Kakizaki rats.

Authors:  Z J Cheng; T Vaskonen; I Tikkanen; K Nurminen; H Ruskoaho; H Vapaatalo; D Muller; J K Park; F C Luft; E M Mervaala
Journal:  Hypertension       Date:  2001-02       Impact factor: 10.190

5.  Biphasic response of cardiac NO synthase isoforms to ischemic preconditioning in conscious rabbits.

Authors:  Y T Xuan; X L Tang; Y Qiu; S Banerjee; H Takano; H Han; R Bolli
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-11       Impact factor: 4.733

6.  Expression of the three nitric oxide synthase isoforms and nitric oxide level in the rat heart during cold storage and blood reperfusion.

Authors:  M Desrois; T Caus; C Dalmasso; C Lan; P J Cozzone; M Bernard
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  2009-12-20       Impact factor: 1.770

Review 7.  Mitochondrial dysfunction and lipotoxicity.

Authors:  Patrick Schrauwen; Vera Schrauwen-Hinderling; Joris Hoeks; Matthijs K C Hesselink
Journal:  Biochim Biophys Acta       Date:  2009-09-24

8.  Contribution of glucose tolerance and gender to cardiac adiposity.

Authors:  Patricia Iozzo; Riikka Lautamaki; Ronald Borra; Hanna-Riikka Lehto; Marco Bucci; Antti Viljanen; Jussi Parkka; Virva Lepomaki; Romina Maggio; Riitta Parkkola; Juhani Knuuti; Pirjo Nuutila
Journal:  J Clin Endocrinol Metab       Date:  2009-10-09       Impact factor: 5.958

9.  Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging.

Authors:  Luuk J Rijzewijk; Rutger W van der Meer; Hildo J Lamb; Hugo W A M de Jong; Mark Lubberink; Johannes A Romijn; Jeroen J Bax; Albert de Roos; Jos W Twisk; Robert J Heine; Adriaan A Lammertsma; Johannes W A Smit; Michaela Diamant
Journal:  J Am Coll Cardiol       Date:  2009-10-13       Impact factor: 24.094

10.  Endothelial dysfunction in the early- and late-stage type-2 diabetic Goto-Kakizaki rat aorta.

Authors:  Emi Kazuyama; Motoaki Saito; Yukako Kinoshita; Itaru Satoh; Fotios Dimitriadis; Keisuke Satoh
Journal:  Mol Cell Biochem       Date:  2009-06-20       Impact factor: 3.396

View more
  17 in total

1.  Voltage dependence of the Ca2+ transient in endocardial and epicardial myocytes from the left ventricle of Goto-Kakizaki type 2 diabetic rats.

Authors:  Lina Al Kury; Vadym Sydorenko; Manal M A Smail; Muhammad Anwar Qureshi; Anatoliy Shmygol; Murat Oz; Jaipaul Singh; Frank Christopher Howarth
Journal:  Mol Cell Biochem       Date:  2018-01-09       Impact factor: 3.396

2.  Sex Differences in Metabolic Cardiomyopathy.

Authors:  Elizabeth Murphy; Georgios Amanakis; Natasha Fillmore; Randi J Parks; Junhui Sun
Journal:  Cardiovasc Res       Date:  2017-02-01       Impact factor: 10.787

3.  Tissue-specific up-regulation of arginase I and II induced by p38 MAPK mediates endothelial dysfunction in type 1 diabetes mellitus.

Authors:  J Pernow; A Kiss; Y Tratsiakovich; B Climent
Journal:  Br J Pharmacol       Date:  2015-08-10       Impact factor: 8.739

Review 4.  Cardiac NO signalling in the metabolic syndrome.

Authors:  O Pechánová; Z V Varga; M Cebová; Z Giricz; P Pacher; P Ferdinandy
Journal:  Br J Pharmacol       Date:  2014-12-15       Impact factor: 8.739

Review 5.  Guidelines on models of diabetic heart disease.

Authors:  Lisa C Heather; Anne D Hafstad; Ganesh V Halade; Romain Harmancey; Kimberley M Mellor; Paras K Mishra; Erin E Mulvihill; Miranda Nabben; Michinari Nakamura; Oliver J Rider; Matthieu Ruiz; Adam R Wende; John R Ussher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-06-03       Impact factor: 5.125

6.  Obesity improves myocardial ischaemic tolerance and RISK signalling in insulin-insensitive rats.

Authors:  Daniel Donner; John P Headrick; Jason N Peart; Eugene F du Toit
Journal:  Dis Model Mech       Date:  2012-11-16       Impact factor: 5.758

7.  Hyperactive S6K1 mediates oxidative stress and endothelial dysfunction in aging: inhibition by resveratrol.

Authors:  Angana G Rajapakse; Gautham Yepuri; João M Carvas; Sokrates Stein; Christian M Matter; Isabelle Scerri; Jean Ruffieux; Jean-Pierre Montani; Xiu-Fen Ming; Zhihong Yang
Journal:  PLoS One       Date:  2011-04-22       Impact factor: 3.240

8.  The diabetic heart: too sweet for its own good?

Authors:  Hannah J Whittington; Girish G Babu; Mihaela M Mocanu; Derek M Yellon; Derek J Hausenloy
Journal:  Cardiol Res Pract       Date:  2012-02-22       Impact factor: 1.866

9.  Perspectives of Targeting mTORC1-S6K1 in Cardiovascular Aging.

Authors:  Xiu-Fen Ming; Jean-Pierre Montani; Zhihong Yang
Journal:  Front Physiol       Date:  2012-01-25       Impact factor: 4.566

10.  Arginase: the emerging therapeutic target for vascular oxidative stress and inflammation.

Authors:  Zhihong Yang; Xiu-Fen Ming
Journal:  Front Immunol       Date:  2013-06-12       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.